InvestorsHub Logo
Followers 27
Posts 1014
Boards Moderated 0
Alias Born 08/19/2016

Re: None

Saturday, 12/10/2016 7:14:57 PM

Saturday, December 10, 2016 7:14:57 PM

Post# of 403226
SGX942 is NOT a prevention as B-OM is intended.

It just cuts the time in 1/2 that patients suffer with OM.
SGX942 successfully reduced the median duration of severe OM by 50% in all patients and by 67% in patients at highest risk of developing severe OM.

Not even a competitor if B-OM results are good.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News